Intrinsic Medicine Inc is a preclinical-stage therapeutics company leveraging synthetic biology-manufactured HiMO molecules as new medicines to treat large patient populations underserved by treatment options. The company's initial drug candidates are based on bioactive oligosaccharides naturally produced in human milk, or HMOs, which directly modulate the immune system and other human cells as well as the gut microbiome.
No Data
No Data
No Data
No Data
No Data
No Data
No Data
No Data